• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Edwards Lifesciences shares fall on Street-beating Q1 results

Edwards Lifesciences shares fall on Street-beating Q1 results

April 26, 2022 By Jim Hammerand

Edwards LifesciencesEdwards Lifesciences (NYSE: EW) posted first-quarter results today that beat the consensus forecast on Wall Street.

It also reaffirmed its outlook for the rest of the year, with CEO Michael Mussallem saying, “We are hopeful the worst of the pandemic is behind us.”

The Irvine, California–based cardio device company reported profits of $373.6 million, or $0.59 per diluted share, on sales of $1.34 billion for the three months ended March 31, 2022. That was a 10% increase in both the bottom line and sales compared with Q1 2021.

Adjusted to exclude one-time items, earnings per share were $0.60, $0.03 over Wall Street analysts’ expectations of $0.57 on sales of $1.31 billion.

“We were pleased with our first-quarter results despite the pronounced impact that omicron had on hospital capacity, resources, and procedure volumes in January. Our supply chain team delivered, and our field employees continued to support the skilled clinicians and patients who count on Edwards,” Mussallem said in a news release. “… We continue to believe that 2022 will be an important year for Edwards, as we expect low double-digit sales growth and meaningful progress on our pursuit of significant opportunities to improve patient care.”

Transcatheter aortic valve replacement (TAVR) sales grew 11% to $881 million, while surgical structural heart sales ticked up 4% to $221 million.

Edwards reaffirmed its 2022 profit and revenue guidance at $2.50 to $2.65 in adjusted EPS on sales of $5.5 billion to $6 billion.

The company said it expects adjusted EPS of $0.61 to $0.69 for the second quarter on revenue between $1.36 billion and $1.44 billion.

Investors reacted to the financial results by sending EW shares down more than 5% to $110.00 in after-hours trading.

BTIG analysts noted that the Q2 revenue projection was slightly below the $1.452 billion Wall Street consensus. Analysts Marie Thibault and Sam Eiber also mentioned that management predicted an additional $70 million in foreign exchange headwinds for the year, on top of the $100 million already projected. In addition, hospitals volumes are not fully back to normal post-omicron, and there are inflationary and labor cost pressures.

“In an unforgiving stock market, we think EW shares are likely to trade lower on Wednesday as investors digest this commentary and the below-consensus Q2 revenue guide,” Thibault and Eiber said.

The next day — on Wednesday — the stock dropped about 4% from the prior day’s close, trading around $112 near mid-day. MassDevice and MDO‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was down slightly.

This post was updated on April 27 with next-day stock performance.

Filed Under: Blog, Business/Financial News, Cardiovascular, Featured, MassDevice Earnings Roundup, News Well, Replacement Heart Valves, Structural Heart, Wall Street Beat Tagged With: BTIG, Edwards Lifesciences, Michael Mussallem

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

About Jim Hammerand

Jim Hammerand is the managing editor of Medical Design & Outsourcing. He has more than two decades of journalism experience spanning newspapers, magazines, websites, live events, radio and TV news. For nearly a decade, Hammerand reported and edited business news for American City Business Journals as a reporter and digital editor at the Minneapolis/St. Paul Business Journal and then managing editor of the Puget Sound Business Journal in Seattle. He holds a bachelor’s degree in journalism from the University of Minnesota. He is based near Seattle, Washington, where he and his family live. Connect with him on LinkedIn or by email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy